
- This event has passed.
PAUSE Seminar: Personalized Strategies to Prevent and Treat Bacterial Infections in Neutropenic Patients
November 15, 2024 @ 9:15 am - 10:15 am

Michael Satlin, MD, MS, FIDSA, is an infectious diseases physician and Associate Professor of Medicine and of Pathology and Laboratory Medicine at Weill Cornell Medicine. He is the Clinical Director of the Transplantation-Oncology Infectious Diseases Program at Weill Cornell. He completed medical school at the University of Virginia School of Medicine and internal medicine residency and infectious diseases fellowship training at NewYork-Presbyterian Hospital/Weill Cornell. He also obtained a Master’s Degree in Clinical and Translational Investigation at Weill Cornell. His research focuses on the epidemiology, prevention, and treatment of multidrug-resistant Gram-negative infections, with a focus on immunocompromised hosts. He has authored or co-authored over 110 peer-reviewed manuscripts and has received grant funding for his research from the National Institute of Allergy and Infectious Diseases (NIAID) since 2014. He is Co-Chair of the Breakpoint Working Group of the Clinical and Laboratory Standards Institute’s (CLSI) Subcommittee on Antimicrobial Susceptibility Testing and a Member of the Infectious Diseases Society of America’s (IDSA) guidance panel for the treatment of antibiotic-resistant Gram-negative infections. He is also Vice Chair of the Gram-Negative Subcommittee of NIAID’s Antibacterial Resistance Leadership Group and Senior Editor of Journal of Antimicrobial Chemotherapy-Antimicrobial Resistance.